Enzyme-linked immunosorbent assay detection of prostate-specific antigen messenger ribonucleic acid in prostate cancer

Urology

Volumn 53, Issue 1, 1999, Pages 228-235

  Hoshi, Senji ^a   Kobayashi, Satsuki ^a   Takahashi, Toshiko ^a   Suzuki, Ken Ichi ^a   Kawamura, Sadafumi ^a   Satoh, Makoto ^a   Chiba, Yutaka ^a   Orikasa, Seiichi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; ASPIRATION BIOPSY; BLADDER CANCER; CANCER CELL CULTURE; COLORIMETRY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PELVIS LYMPH NODE; PENIS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UROGENITAL TRACT CANCER;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RNA; TUMOR CELLS, CULTURED;

EID: 0032950764     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00416-6     Document Type: Article

References (23)

1. Moreno J.G., Croce C.M., Fischer R., et al. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res. 52:1992;6110-6112.
2. Katz A.E., Olsson C.A., Raffo A., et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology. 43:1994;765-775.
3. Horoszwicz J.S., Leong S.S., Kawinski E., et al. LNCaP model of human prostate carcinoma. Cancer Res. 43:1983;1809-1818.
4. Kaighn M.E., Shankar N., Ohnuki Y., et al. Establishment and characterization of a human prostate carcinoma cell line (PC-3). Invest Urol. 17:1979;16-23.
5. Stone K.R., Mickey D.D., Wunderli H., et al. Isolation of a human prostate carcinoma cell line (DU-145). Int J Cancer. 21:1978;274-281.
6. Hoshi S. Evaluation of neoadjuvant therapy in locally invasive bladder cancer core biopsy of bladder tumor and aspiration biopsy of regional lymph nodes . Villavicencio H., Fair W.R. Evaluation of Chemotherapy Invasive Bladder Cancer. 1992;61-77 Churchill Livingstone, New York.
7. Myers T.W., Gelfand D.H. Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry. 30:1991;7661-7666.
8. Young K.K., Resnick R.M., Myers T.W. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol. 31:1993;882-886.
9. Lundwall A., Lilja H. Molecular cloning of human prostate specific antigen cDNA. FEBS Lett. 214:1987;317-322.
10. Riegman P.H.J., Vlietstra R.J., van der Korput H.A.G.M., et al. Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species. Mol Cell Endocrinol. 76:1991;181-190.
11. General Rules for Clinical and Pathological Studies on Prostate Cancer, 2nd ed. Japanese Urological Association, The Japanese Pathological Society, 1992.
12. Hoshi S., Orikasa S., Takahashi T., et al. Genetic diagnosis of pelvic lymph node metastasis using fine needle aspiration samples in prostate cancer. Acta Urol Jpn. 42:1996;781-785.
13. Takahashi T., Hoshi S., Orikasa S., et al. Genetic diagnosis of pelvic lymph node metastasis in prostate cancer (abstract). J Urol. 155:(Pt 2):1996;378A.
14. Catarona W.J., Richie J.P., Ahmann F.R., et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer result of a multicenter clinical trial of 6,630 men . J Urol. 151:1994;1283-1290.
15. Bichi R., Martinazzo G., Gomella L.G., et al. C-trak detection of RT-PCR PSA products in prostate cancer molecular staging (abstract). J Urol. 155:(Pt 2):1996;553A.
16. Sokoloff M.H., Tso C.L., Kaboo R., et al. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging a clinicopathological molecular analysis of 121 patients . J Urol. 156:1996;1560-1566.
17. Deguchi T., Doi T., Ehara H., et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 53:1993;5350-5354.
18. Edelstein R.A., Zietman A.L., de las Morenas A., et al. Implications of prostatic micrometastases to the pelvic lymph nodes an archival tissue study . Urology. 47:1996;370-375.
19. Vessella R.L., Riley D.E., Blouke K.A., et al. A sensitive method for detection of a prostate tumor cell marker using the polymerase chain reaction (abstract). J Urol. 147:(Pt 2):1992;441A.
20. Cama C., Olsson C.A., Buttyan R., et al. Molecular staging of prostate cancer. III. Effect of cystoscopy and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay. J Urol. 157:1997;1748-1751.
21. Dumas F., Eshwege P., Le Maire V., et al. Blood prostatic epithelial cells detection during radical surgery and transurethral resection (abstract). J Urol. 157:(Pt 2):1997;394A.
22. Saporta F., Thiounn N., Zerbib M., et al. The detection of circulating cells by RT-PCR before and after surgery (abstract). J Urol. 157:(Pt 2):1997;394A.
23. Gomella L.G., Raj G.V., Moreno J.G. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. J Urol. 158:1997;326-337.